Category Archives: Samumed

Brief Items of Interest, October 2017

— In August, I covered groundbreaking new research related to successful hair regeneration in mice. The work was led by scientists from USC (in particular, Dr. Mingxing Lei and Dr. Cheng-Ming Chuong). For some reason, a new CNBC article on this now relatively old news appeared in October and became the most widely covered hair related story this month. Three different people posted the exact same CNBC link in the comments to the last post, and one person even responded with two different takes to the exact same link and story. To be fair, even people on Reddit Futurology (where a week old story is old news) seemed to think that this was a new development.

— Thanks to commentator “Karl” for posting a link to a new study from China regarding electrodynamic microneedling in the comments to my Indian microneedling post from August. Yet again, microneedling seems to lead to significantly increased hair growth when used in conjunction with Minoxidil versus when using just Minoxidil by itself. However, even more interesting, microneedling by itself led to more hair growth than Minoxidil by itself in this study (EDIT: per several commentators who read the full study, this is not accurate and at best you can only say that both resulted in equal new hair growth). Totally crazy that something like wounding works better than one of the only two ever FDA approved hair loss treatments out there. Of course more such results need to be emulated before this becomes believable.

Follica has for a long time claimed that skin disruption in and of itself leads to new de novo hair follicle growth. In the India microneedling post, “Karl” made an interesting lengthy comment related to the above study, and it is worth a read in its entirety. I will paste part of it related to needling depth here:

“Personal observation: that difference of 1.5mm to 2.5mm might seem small, but if you’ve ever done it, you know that it’s HUGE. 1.5mm hurts a lot already, and for some people is borderline unbearable. 2.5mm is getting into torture level lol. Pity they weren’t more specific about their procedure. The question of depth, wounding, and scarring seems an open question in research afaik and is discussed frequently on forums”.

— Samumed added a new page on its site regarding the status of each of its clinical trials. They just Tweeted that link.

— Seems like commentator “egghead” gave great advice regarding waiting to buy a newly public company after the initial turbulence is over. HAIR stock down drastically in the past 3 days.

PolarityTE latest press release and new video.

— Replicel’s hair loss work covered in Forbes magazine.

Fecal matter transplant regrows hair in two alopecia areata patients.

— Dr. David Saceda has been responding to questions by “Tim”. It looks like better ways of measuring DHT and other hormone levels during messotherapy with Dutasteride treatments might be necessary.

Brief Items of Interest, April 2017

Hair loss news first:

— A great story on Dr. Rox Anderson that was also retweeted by PureTech CEO Daphne Zohar:

In the article, Mr. Anderson is praised by the famous hair loss researcher Dr. George Cotsarelis as being a modern day Dr. Benjamin Franklin. Several people that I highly respect have in the past recommended my reading Dr. Franklin’s autobiography, but the one time I tried, I fell asleep very soon after commencing. If I recall correctly, the English was a bit antiquated and difficult to comprehend in my edition.

— Of the numerous companies working on hair growth related products around the world, US based Samumed has been by far and away the best at getting coverage in major print and online publications. This month, they appeared in Business Insider. Dr. Osman Kibar, the CEO of Samumed, is a great poker player. I hope that he is not bluffing the world in real life too. Key quote:

The $12 billion valuation Samumed has right now is based on the $300 million it has raised over the years. The valuation grew based on its lead compound, with the rest of the pipeline thrown in as a “freebie,” Kibar said.

The Business Insider article became a very popular discussion topic on reddit with some interesting comments. Samumed also appeared in Forbes magazine yet again at the beginning of this month.

— Every 6 months or so, the highly unusual case study known as Mr. “Peter Renardo” posts updates in the comments in here. I still insist never ever even considering such an extreme artery ligature procedure, but do make sure to read Peter’s comments.

Topical Dutasteride would be something that I would seriously consider (h/t commentator “Hairplz”).

— Most people’s favorite hair loss researcher Dr. Takashi Tsuji recently came out with a new study/paper titled “Functional Hair Follicle Regeneration by the Rearrangement of Stem Cells”. However, it is in mice and perhaps not especially groundbreaking (see the 5 or so comments in here after “Paul Phoenix” ‘s comment with the study link in there from April 1 at 12:36 pm — you might see a different time in there depending on your location).

— As if it were not enough that hair loss is connected to higher rates of heart disease (“bing” it), it seems like grey hair might also be linked to higher rates of heart disease. Quote: “Atherosclerosis and hair greying occur through similar biological pathways”.

— When I read this article a week ago, I was certain that it was an exaggeration or a translation error. I contacted HairClone CEO Dr. Paul Kemp and he said that the company’s plans remain the same as outlined in his earlier comments on this blog from a few months ago. In any case, if you have any questions about HairClone, you can ask in the comments to this post and Dr. Kemp will come by and respond when he has some free time. Alternatively, you can ask in this thread on hairsite. And no, hair cloning is definitely not yet here in spite of flashy article titles.

Jason McAteer hair transplant.

And now on to medical items of interest:

— I covered the much hyped skin gun and its inventor Dr. Jörg Gerlach on this blog before (see 2011 video here). I was glad to read a new article on this as I thought that RenovaCare might have given up on this technology. anyone?

— Japan is becoming renowned for medical research, not surprising considering its aging population. A Japanese man recently became the first to receive “reprogrammed” stem cells from another person.

— After reading this post (and a few others on this blog), you might think that I am a very biased Japanophile. However, this is not true…and I had to insert that disclaimer before I included the following Japan focused thought here:

For many years, I have noticed that each time the oldest person in the world died, virtually half the time it was a Japanese person. Of course since birth certificates were nonexistent in most developing countries 100 plus years ago, these statistics are biased towards people from developed countries. Nevertheless, after the oldest person (who I covered on this blog in the past) in the world died yesterday, I went to the the wikipedia list of supercentenarians, and lo an behold, 5 of the oldest 10 people in the world at the moment are Japanese.

Interesting article on extending lifespan.

Update on developing pig organs for human transplants.

Half man, half machine.

— US and Chinese teams collaborate and expand stem cell abilities.

CRISPR gene editing to supercharge agriculture.